S&P 500   3,870.29 (-0.81%)
DOW   31,391.52 (-0.46%)
QQQ   318.40 (-1.60%)
AAPL   125.12 (-2.09%)
MSFT   233.87 (-1.30%)
FB   259.00 (-2.23%)
GOOGL   2,064.48 (-0.25%)
TSLA   686.44 (-4.45%)
AMZN   3,094.53 (-1.64%)
NVDA   536.25 (-3.15%)
BABA   234.42 (-3.01%)
CGC   35.25 (+1.50%)
GE   12.98 (-0.99%)
MU   91.09 (-3.87%)
NIO   43.29 (-13.00%)
AMD   84.13 (-2.62%)
T   28.22 (+0.46%)
F   12.55 (+4.76%)
ACB   11.03 (-0.09%)
DIS   193.94 (-0.53%)
BA   223.14 (-0.56%)
NFLX   547.82 (-0.51%)
BAC   35.53 (-0.73%)
S&P 500   3,870.29 (-0.81%)
DOW   31,391.52 (-0.46%)
QQQ   318.40 (-1.60%)
AAPL   125.12 (-2.09%)
MSFT   233.87 (-1.30%)
FB   259.00 (-2.23%)
GOOGL   2,064.48 (-0.25%)
TSLA   686.44 (-4.45%)
AMZN   3,094.53 (-1.64%)
NVDA   536.25 (-3.15%)
BABA   234.42 (-3.01%)
CGC   35.25 (+1.50%)
GE   12.98 (-0.99%)
MU   91.09 (-3.87%)
NIO   43.29 (-13.00%)
AMD   84.13 (-2.62%)
T   28.22 (+0.46%)
F   12.55 (+4.76%)
ACB   11.03 (-0.09%)
DIS   193.94 (-0.53%)
BA   223.14 (-0.56%)
NFLX   547.82 (-0.51%)
BAC   35.53 (-0.73%)
S&P 500   3,870.29 (-0.81%)
DOW   31,391.52 (-0.46%)
QQQ   318.40 (-1.60%)
AAPL   125.12 (-2.09%)
MSFT   233.87 (-1.30%)
FB   259.00 (-2.23%)
GOOGL   2,064.48 (-0.25%)
TSLA   686.44 (-4.45%)
AMZN   3,094.53 (-1.64%)
NVDA   536.25 (-3.15%)
BABA   234.42 (-3.01%)
CGC   35.25 (+1.50%)
GE   12.98 (-0.99%)
MU   91.09 (-3.87%)
NIO   43.29 (-13.00%)
AMD   84.13 (-2.62%)
T   28.22 (+0.46%)
F   12.55 (+4.76%)
ACB   11.03 (-0.09%)
DIS   193.94 (-0.53%)
BA   223.14 (-0.56%)
NFLX   547.82 (-0.51%)
BAC   35.53 (-0.73%)
S&P 500   3,870.29 (-0.81%)
DOW   31,391.52 (-0.46%)
QQQ   318.40 (-1.60%)
AAPL   125.12 (-2.09%)
MSFT   233.87 (-1.30%)
FB   259.00 (-2.23%)
GOOGL   2,064.48 (-0.25%)
TSLA   686.44 (-4.45%)
AMZN   3,094.53 (-1.64%)
NVDA   536.25 (-3.15%)
BABA   234.42 (-3.01%)
CGC   35.25 (+1.50%)
GE   12.98 (-0.99%)
MU   91.09 (-3.87%)
NIO   43.29 (-13.00%)
AMD   84.13 (-2.62%)
T   28.22 (+0.46%)
F   12.55 (+4.76%)
ACB   11.03 (-0.09%)
DIS   193.94 (-0.53%)
BA   223.14 (-0.56%)
NFLX   547.82 (-0.51%)
BAC   35.53 (-0.73%)
Log in
ASX:NYR

Nyrada Competitors

Add
Compare
Today's Range N/A
50-Day Range
A$0.17
MA: A$0.16
A$0.17
52-Week Range N/A
Volume65,000 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

Nyrada (ASX:NYR) Vs. CHV, DDXS, PREV, TNGN, COM, and MYM

Should you be buying NYR stock or one of its competitors? Companies in the industry of "biotechnology" are considered alternatives and competitors to Nyrada, including (CHV) (CHV), (DDXS) (DDXS), (PREV) (PREV), (TNGN) (TNGN), 138267 (COM.TO) (COM), and 17031 (MYM).

(CHV) (CNSX:CHV) and Nyrada (ASX:NYR) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, analyst recommendations, earnings, institutional ownership, dividends, valuation and risk.

Analyst Ratings

This is a summary of recent ratings and price targets for (CHV) and Nyrada, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
(CHV)0000N/A
Nyrada0000N/A

Profitability

This table compares (CHV) and Nyrada's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
(CHV)N/AN/AN/A
NyradaN/AN/AN/A

Valuation and Earnings

This table compares (CHV) and Nyrada's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
(CHV)N/AN/AN/AN/AN/A
Nyrada$1.18 million0.00$-6,317,082.00A($0.06)N/A

(CHV) has higher earnings, but lower revenue than Nyrada.

Summary

Nyrada beats (CHV) on 1 of the 1 factors compared between the two stocks.

Nyrada (ASX:NYR) and (DDXS) (OTCMKTS:DDXS) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, analyst recommendations, valuation, institutional ownership, risk, earnings and dividends.

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Nyrada and (DDXS), as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Nyrada0000N/A
(DDXS)0000N/A

Profitability

This table compares Nyrada and (DDXS)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
NyradaN/AN/AN/A
(DDXS)N/AN/AN/A

Valuation & Earnings

This table compares Nyrada and (DDXS)'s gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Nyrada$1.18 million0.00$-6,317,082.00A($0.06)N/A
(DDXS)N/AN/AN/AN/AN/A

(DDXS) has lower revenue, but higher earnings than Nyrada.

Summary

Nyrada beats (DDXS) on 1 of the 1 factors compared between the two stocks.

Nyrada (ASX:NYR) and (PREV) (CNSX:PREV) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, analyst recommendations, valuation, institutional ownership, risk, earnings and dividends.

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Nyrada and (PREV), as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Nyrada0000N/A
(PREV)0000N/A

Profitability

This table compares Nyrada and (PREV)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
NyradaN/AN/AN/A
(PREV)N/AN/AN/A

Valuation & Earnings

This table compares Nyrada and (PREV)'s gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Nyrada$1.18 million0.00$-6,317,082.00A($0.06)N/A
(PREV)N/AN/AN/AN/AN/A

(PREV) has lower revenue, but higher earnings than Nyrada.

Summary

Nyrada beats (PREV) on 1 of the 1 factors compared between the two stocks.

Nyrada (ASX:NYR) and (TNGN) (OTCMKTS:TNGN) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, analyst recommendations, valuation, institutional ownership, risk, earnings and dividends.

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Nyrada and (TNGN), as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Nyrada0000N/A
(TNGN)0000N/A

Profitability

This table compares Nyrada and (TNGN)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
NyradaN/AN/AN/A
(TNGN)N/AN/AN/A

Valuation & Earnings

This table compares Nyrada and (TNGN)'s gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Nyrada$1.18 million0.00$-6,317,082.00A($0.06)N/A
(TNGN)N/AN/AN/AN/AN/A

(TNGN) has lower revenue, but higher earnings than Nyrada.

Summary

Nyrada beats (TNGN) on 1 of the 1 factors compared between the two stocks.

Nyrada (ASX:NYR) and 138267 (COM.TO) (TSE:COM) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, analyst recommendations, valuation, institutional ownership, risk, earnings and dividends.

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Nyrada and 138267 (COM.TO), as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Nyrada0000N/A
138267 (COM.TO)0000N/A

Profitability

This table compares Nyrada and 138267 (COM.TO)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
NyradaN/AN/AN/A
138267 (COM.TO)N/AN/AN/A

Valuation & Earnings

This table compares Nyrada and 138267 (COM.TO)'s gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Nyrada$1.18 million0.00C$-6,317,082.00A($0.06)N/A
138267 (COM.TO)N/AN/AN/AN/AN/A

138267 (COM.TO) has lower revenue, but higher earnings than Nyrada.

Summary

Nyrada beats 138267 (COM.TO) on 1 of the 1 factors compared between the two stocks.

Nyrada (ASX:NYR) and 17031 (CNSX:MYM) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, analyst recommendations, valuation, institutional ownership, risk, earnings and dividends.

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Nyrada and 17031, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Nyrada0000N/A
170310000N/A

Profitability

This table compares Nyrada and 17031's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
NyradaN/AN/AN/A
17031N/AN/AN/A

Valuation & Earnings

This table compares Nyrada and 17031's gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Nyrada$1.18 million0.00C$-6,317,082.00A($0.06)N/A
17031N/AN/AN/AN/AN/A

17031 has lower revenue, but higher earnings than Nyrada.

Summary

Nyrada beats 17031 on 1 of the 1 factors compared between the two stocks.


Nyrada Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
CHV
(CHV)
0.5N/AN/A$0.00N/A0.00High Trading Volume
(DDXS) logo
DDXS
(DDXS)
0.5$0.00flat$0.00N/A0.00
PREV
(PREV)
0.7N/AN/A$0.00N/A0.00High Trading Volume
TNGN
(TNGN)
0.4N/AN/A$0.00N/A0.00Gap Up
COM
138267 (COM.TO)
0.5$2.95flatC$0.00N/A0.00
MYM
17031
0.4N/AN/AC$0.00N/A0.00
4BB
4basebio UK Societas
0.3$300.00flat£0.00N/A0.00
ATTBF
Abattis Bioceuticals
0.4$0.02flat$0.00N/A0.00Gap Up
Abzena plc (ABZA.L) logo
ABZA
Abzena plc (ABZA.L)
0.6$15.75flat£0.00N/A0.00
ACR
Acrux
0.9N/AN/A$0.00$1.25 million0.00High Trading Volume
Gap Up
ACW
Actinogen Medical
0.5N/AN/A$0.00$2.84 million0.00High Trading Volume
Gap Up
1AD
AdAlta
0.5N/AN/A$0.00$4.23 million0.00High Trading Volume
Gap Up
ADTX
ADiTx Therapeutics
1.0$3.22flat$0.00N/A0.00Decrease in Short Interest
AHZ
Admedus
0.5N/AN/A$0.00N/A0.00High Trading Volume
AGNPF
Algernon Pharmaceuticals
0.0$0.27flat$0.00N/A0.00Gap Down
Almirall logo
LBTSF
Almirall
0.5$12.40flat$0.00N/A0.00Increase in Short Interest
AMBS
Amarantus BioScience
0.5N/AN/A$0.00N/A0.00High Trading Volume
ATX
Amplia Therapeutics
0.8N/AN/A$0.00$894,155.000.00High Trading Volume
Gap Up
ANR
Anatara Lifesciences
0.5N/AN/A$0.00$268,259.000.00High Trading Volume
Gap Up
ANVS
Annovis Bio
0.0N/AN/A$0.00N/A0.00High Trading Volume
CBDC
Apotheca Biosciences
0.4$0.03flat$0.00N/A0.00Gap Down
ARNI
Arno Therapeutics
0.5$0.00flat$0.00N/A0.00Gap Down
ASCLF
Ascletis Pharma
0.4$0.37flat$0.00N/A0.00
CDMOP
Avid Bioservices
0.3$30.95flat$0.00N/A0.00Increase in Short Interest
AXIM
AXIM Biotechnologies
0.4$0.71flat$0.00N/A0.00Gap Down
BXRXV
Baudax Bio
0.5$4.51flat$0.00N/A0.00High Trading Volume
BRRGF
BerGenBio ASA
0.7$3.88flat$0.00N/A0.00Decrease in Short Interest
BGT
Bio-Gene Technology
0.5N/AN/A$0.00$82,795.000.00High Trading Volume
News Coverage
Gap Up
BNO
Bionomics Limited (BNO.AX)
0.5N/AN/A$0.00$3.19 million0.00High Trading Volume
Gap Up
BIT
Biotron
0.5N/AN/A$0.00$853,026.000.00High Trading Volume
Gap Up
BXN
Bioxyne
0.5N/AN/A$0.00$2.15 million0.00High Trading Volume
Gap Up
BOT
Botanix Pharmaceuticals
0.5N/AN/A$0.00$7.56 million0.00High Trading Volume
Gap Up
BPH
BPH Energy
0.5N/AN/A$0.00$240,243.000.00High Trading Volume
Gap Up
BTC
BTC Health
0.8N/AN/A$0.00$131,934.000.00High Trading Volume
News Coverage
Gap Up
CNBX
Cannabics Pharmaceuticals
0.4$0.37flat$0.00N/A0.00Gap Up
ORHOF
CannaRoyalty
0.7$9.23flat$0.00N/A0.00Gap Down
CDXI
Cardax
0.0N/AN/A$0.00N/A0.00High Trading Volume
CDY
Cellmid Limited (CDY.AX)
0.8N/AN/A$0.00$6.61 million0.00High Trading Volume
Gap Up
CBBT
Cerebain Biotech
0.0$0.11flat$0.00N/A0.00High Trading Volume
Increase in Short Interest
Gap Up
CGYG
China Longyi Group International
0.4$0.00flat$0.00N/A0.00
CUV
Clinuvel Pharmaceuticals
0.6N/AN/A$0.00$38.34 million0.00High Trading Volume
Gap Up
CLVLY
Clinuvel Pharmaceuticals
1.0$18.93flat$0.00N/A0.00High Trading Volume
Gap Down
CELZ
Creative Medical Technology
0.5$0.04flat$0.00N/A0.00Decrease in Short Interest
Gap Up
CSL Limited (CSL.AX) logo
CSL
CSL Limited (CSL.AX)
0.8N/AN/A$0.00$9.98 billion0.00Dividend Announcement
High Trading Volume
Gap Up
CLXPF
Cybin
1.0$1.26flat$0.00N/A0.00Decrease in Short Interest
News Coverage
CYP
Cynata Therapeutics
0.5N/AN/A$0.00$2.60 million0.00High Trading Volume
News Coverage
Gap Up
CURE
Direxion Daily Healthcare Bull 3X Shares
0.5N/AN/A$0.00N/A0.00High Trading Volume
Gap Down
ETBI
Eastgate Biotech
0.5$0.00flat$0.00N/A0.00
EMMBF
Emblem
0.6$1.40flat$0.00N/A0.00
ENZC
Enzolytics
0.0$0.48flat$0.00N/A0.00Increase in Short Interest
Gap Down
This page was last updated on 3/2/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.